Clearly the average daily scripts written in the week after Memorial Day was barely changed when compared to the week of Memorial Day. Worse yet, in over a month, it's barely up at all. For a "lifesaving drug" launched just less than 3 months before the data above, one would think there would be more of an acceleration of new prescriptions being written by doctors. Since there's between 250 and 300 AMRN sales reps at any one time, the average rep can be accredited essentially for 1-2 prescriptions per day. If the average doctor who starts writing prescriptions for his patients writes 5-10 of them per day, that would mean on average 20% of the sales reps have signed up 1 doctor each and 80% of AMRN's sales reps have yet to sign up a single doctor yet. The drug, thus so, is a commercial failure and AMRN is dead at this pace.